Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon
- PMID: 30508493
- PMCID: PMC6304724
- DOI: 10.1177/0033354918813552
Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon
Abstract
Objectives: Given the known high morbidity and mortality of hepatitis C virus (HCV) infection in Oregon, we sought to develop a practical method of estimating the severe sequelae of HCV infection among Medicaid beneficiaries in Oregon.
Methods: We assembled a retrospective cohort that identified all Oregon Medicaid beneficiaries with HCV infection enrolled for at least 1 year during 2009-2013. We linked this cohort to 3 data sets to identify HCV-related deaths, cases of hepatocellular carcinoma (HCC), and first hospitalizations for advanced liver disease (ALD). We calculated incidence density rates and used multivariable Cox regression modeling to calculate adjusted hazard ratios (aHRs) to evaluate the association between demographic characteristics (birth year, sex, race, ethnicity) and these 3 outcomes.
Results: Of 11 790 Oregon Medicaid beneficiaries with HCV infection, 474 (4.0%) had an HCV-related death, 156 (1.3%) had HCC, and 596 (5.1%) had a first hospitalization for ALD. Adjusted hazard ratios for deaths were 2.2 (95% confidence interval [CI], 1.6-2.8) among persons born in 1945 through 1965 (vs persons born after 1965), 2.1 (95% CI, 1.7-2.5) among males (vs females), and 1.9 (95% CI, 1.2-2.9) among Asian/Pacific Islanders and 2.2 (95% CI, 1.5-3.2) among American Indian/Alaska Natives (vs white persons). The same risk groups had significant aHRs for first hospitalizations for ALD. Persons born before 1945 (aHR = 17.0; 95% CI, 5.2-55.8) and in 1945 through 1965 (aHR = 12.8; 95% CI, 4.1-40.3) vs born after 1965, males (aHR = 3.3; 95% CI, 2.3-4.8) vs females, and Asian/Pacific Islanders (aHR = 3.9; 95% CI, 2.3-6.7) vs white persons had higher risks for HCC.
Conclusions: Continued assessments using the methods piloted in this study will allow Oregon to monitor trends in severe sequelae of HCV infection over time.
Keywords: hepatitis C infection; hepatocellular carcinoma; morbidity; mortality; state-specific epidemiology.
Conflict of interest statement
Similar articles
-
Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17. Clin Gastroenterol Hepatol. 2017. PMID: 27765729 Free PMC article.
-
Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.Am J Gastroenterol. 2014 Sep;109(9):1427-35. doi: 10.1038/ajg.2014.214. Epub 2014 Jul 29. Am J Gastroenterol. 2014. PMID: 25070058
-
Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.Eur J Surg Oncol. 2021 Mar;47(3 Pt B):640-648. doi: 10.1016/j.ejso.2020.10.001. Epub 2020 Oct 7. Eur J Surg Oncol. 2021. PMID: 33051117 Free PMC article.
-
Hepatocellular carcinoma: an epidemiologic view.J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8. doi: 10.1097/00004836-200211002-00002. J Clin Gastroenterol. 2002. PMID: 12394209 Review.
-
Treatment of chronic hepatitis C in Asia: when East meets West.J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. J Gastroenterol Hepatol. 2009. PMID: 19335784 Review.
References
-
- Alter MJ. Hepatitis C virus infection in the United States. J Hepatol. 1999;31(suppl 1):88–91. - PubMed
-
- World Health Organization. Hepatitis C fact sheet. http://www.who.int/mediacentre/factsheets/fs164/en. Updated July 18, 2018. Accessed October 19, 2018.
-
- Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR4):1–32. - PubMed
-
- Xu F, Tong X, Leidner AJ. Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase. Health Aff (Millwood). 2014;33(10):1728–1735. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical